Design and validation of a homogeneous time-resolved fluorescence-based leptin receptor binding assay - PubMed (original) (raw)
Design and validation of a homogeneous time-resolved fluorescence-based leptin receptor binding assay
Virginie Vauthier et al. Anal Biochem. 2013.
Abstract
The pleiotropic cytokine hormone leptin, by activating its receptor OB-R, plays a major role in many biological processes, including energy homeostasis, immune function, and cell survival and proliferation. Abnormal leptin action is associated with obesity, autoimmune diseases, and cancer. The pharmacological characterization of OB-R and the development of synthetic OB-R ligands are still in their infancy because currently available binding assays are not compatible with ligand saturation binding experiments and high-throughput screening (HTS) approaches. We have developed here a novel homogeneous time-resolved fluorescence-based binding assay that overcomes these limitations. In this assay, fluorescently labeled leptin or leptin antagonist binds to the SNAP-tagged OB-R covalently labeled with terbium cryptate (Tb). Successful binding is monitored by measuring the energy transfer between the Tb energy donor and the fluorescently labeled leptin energy acceptor. Ligand binding saturation experiments revealed high-affinity dissociation constants in the subnanomolar range with an excellent signal-to-noise ratio. The assay performed in a 384-well format shows high specificity and reproducibility, making it perfectly compatible with HTS applications to identify new OB-R agonists or antagonists. In addition, fluorescently labeled leptin and SNAP-tagged OB-R will be valuable tools for monitoring leptin and OB-R trafficking in cells and tissues.
Copyright © 2013 Elsevier Inc. All rights reserved.
Similar articles
- Homogeneous time-resolved fluorescence-based assay to screen for ligands targeting the growth hormone secretagogue receptor type 1a.
Leyris JP, Roux T, Trinquet E, Verdié P, Fehrentz JA, Oueslati N, Douzon S, Bourrier E, Lamarque L, Gagne D, Galleyrand JC, M'kadmi C, Martinez J, Mary S, Banères JL, Marie J. Leyris JP, et al. Anal Biochem. 2011 Jan 15;408(2):253-62. doi: 10.1016/j.ab.2010.09.030. Epub 2010 Sep 24. Anal Biochem. 2011. PMID: 20937574 - Molecular dynamics, dynamic site mapping, and highthroughput virtual screening on leptin and the Ob receptor as anti-obesity target.
Tutone M, Pantano L, Lauria A, Almerico AM. Tutone M, et al. J Mol Model. 2014 May;20(5):2247. doi: 10.1007/s00894-014-2247-z. Epub 2014 May 6. J Mol Model. 2014. PMID: 24797089 - Leptin receptor is expressed by tissue mast cells.
Żelechowska P, Wiktorska M, Różalska S, Stasikowska-Kanicka O, Wągrowska-Danilewicz M, Agier J, Brzezińska-Błaszczyk E. Żelechowska P, et al. Immunol Res. 2018 Oct;66(5):557-566. doi: 10.1007/s12026-018-9029-0. Immunol Res. 2018. PMID: 30269202 Free PMC article. - Leptin-Activity Modulators and Their Potential Pharmaceutical Applications.
Greco M, De Santo M, Comandè A, Belsito EL, Andò S, Liguori A, Leggio A. Greco M, et al. Biomolecules. 2021 Jul 16;11(7):1045. doi: 10.3390/biom11071045. Biomolecules. 2021. PMID: 34356668 Free PMC article. Review.
Cited by
- Leptin brain entry via a tanycytic LepR-EGFR shuttle controls lipid metabolism and pancreas function.
Duquenne M, Folgueira C, Bourouh C, Millet M, Silva A, Clasadonte J, Imbernon M, Fernandois D, Martinez-Corral I, Kusumakshi S, Caron E, Rasika S, Deliglia E, Jouy N, Oishi A, Mazzone M, Trinquet E, Tavernier J, Kim YB, Ory S, Jockers R, Schwaninger M, Boehm U, Nogueiras R, Annicotte JS, Gasman S, Dam J, Prévot V. Duquenne M, et al. Nat Metab. 2021 Aug;3(8):1071-1090. doi: 10.1038/s42255-021-00432-5. Epub 2021 Aug 2. Nat Metab. 2021. PMID: 34341568 Free PMC article. - SARS-COV-2 spike binding to ACE2 in living cells monitored by TR-FRET.
Cecon E, Burridge M, Cao L, Carter L, Ravichandran R, Dam J, Jockers R. Cecon E, et al. Cell Chem Biol. 2022 Jan 20;29(1):74-83.e4. doi: 10.1016/j.chembiol.2021.06.008. Epub 2021 Jul 2. Cell Chem Biol. 2022. PMID: 34246414 Free PMC article. - A novel leptin receptor antagonist uncouples leptin's metabolic and immune functions.
Zabeau L, Wauman J, Dam J, Van Lint S, Burg E, De Geest J, Rogge E, Silva A, Jockers R, Tavernier J. Zabeau L, et al. Cell Mol Life Sci. 2019 Mar;76(6):1201-1214. doi: 10.1007/s00018-019-03004-9. Epub 2019 Jan 18. Cell Mol Life Sci. 2019. PMID: 30659329 Free PMC article. - Editorial: Leptin Resistance in Metabolic Disorders: Possible Mechanisms and Treatments.
Hosoi T, Maffei M. Hosoi T, et al. Front Endocrinol (Lausanne). 2017 Nov 2;8:300. doi: 10.3389/fendo.2017.00300. eCollection 2017. Front Endocrinol (Lausanne). 2017. PMID: 29163368 Free PMC article. No abstract available. - Leptin Controls Parasympathetic Wiring of the Pancreas during Embryonic Life.
Croizier S, Prevot V, Bouret SG. Croizier S, et al. Cell Rep. 2016 Apr 5;15(1):36-44. doi: 10.1016/j.celrep.2016.02.088. Epub 2016 Mar 24. Cell Rep. 2016. PMID: 27052164 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous